Bowen Hanes & Co. Inc. Has $51.69 Million Holdings in Xylem Inc. $XYL

Bowen Hanes & Co. Inc. raised its holdings in Xylem Inc. (NYSE:XYLFree Report) by 514.3% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 350,437 shares of the industrial products company’s stock after buying an additional 293,390 shares during the period. Bowen Hanes & Co. Inc. owned about 0.14% of Xylem worth $51,689,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. AQR Capital Management LLC boosted its position in Xylem by 14.4% during the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock worth $3,645,000 after purchasing an additional 3,900 shares during the period. NewEdge Advisors LLC lifted its stake in shares of Xylem by 3.3% during the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock worth $496,000 after buying an additional 132 shares during the last quarter. Empowered Funds LLC lifted its stake in shares of Xylem by 56.1% during the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock worth $1,037,000 after buying an additional 3,120 shares during the last quarter. Chicago Partners Investment Group LLC bought a new stake in shares of Xylem during the 2nd quarter worth about $217,000. Finally, Cullen Frost Bankers Inc. grew its stake in Xylem by 70.2% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 3,766 shares of the industrial products company’s stock valued at $487,000 after buying an additional 1,553 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Stock Performance

NYSE:XYL opened at $128.59 on Friday. The company has a market cap of $31.31 billion, a price-to-earnings ratio of 32.80, a PEG ratio of 1.84 and a beta of 1.17. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $154.27. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.28 and a current ratio of 1.62. The stock has a fifty day moving average price of $137.53 and a 200-day moving average price of $141.62.

Xylem (NYSE:XYLGet Free Report) last posted its quarterly earnings results on Tuesday, February 10th. The industrial products company reported $1.42 EPS for the quarter, meeting analysts’ consensus estimates of $1.42. Xylem had a return on equity of 11.11% and a net margin of 10.59%.The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.37 billion. During the same quarter in the previous year, the firm earned $1.18 earnings per share. Xylem’s revenue for the quarter was up 6.3% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. As a group, equities analysts anticipate that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 24th. Stockholders of record on Tuesday, February 24th will be given a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Tuesday, February 24th. This is a boost from Xylem’s previous quarterly dividend of $0.40. Xylem’s dividend payout ratio is presently 40.82%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on XYL. TD Cowen restated a “hold” rating on shares of Xylem in a report on Friday, December 5th. Weiss Ratings restated a “buy (b-)” rating on shares of Xylem in a research note on Monday, December 29th. Royal Bank Of Canada lowered their price objective on Xylem from $176.00 to $162.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 11th. Zacks Research cut shares of Xylem from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Finally, Barclays lowered their price target on shares of Xylem from $166.00 to $156.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 11th. Nine equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Xylem presently has a consensus rating of “Moderate Buy” and an average price target of $158.08.

Read Our Latest Stock Report on XYL

About Xylem

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Read More

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.